Home
Careers
Conferences
Directory
Drug Discovery
Genes
InDepth
Marketing
News
Reports
Videos
Search
Contact
Items Ordered:
Cart Value:
New Products:
1.
Virtual Pharma - the radical route to success
2.
Manufacturing in the Global Pharmaceuticals Industry Key drivers, company strategies and regulations (3rd Edition)
Best Sellers:
1.
BioNewsCast Press Release Distribution Service
2.
Latest Chinese Regulations for Imported Drug Registration A Comprehensive Guidebook for Foreign Pharmaceutical Companies
3.
5th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production, March 2008
4.
Microarray Markets
5.
Neuropatic Pain - Three Course Suite
6.
Contract Research Annual Review 2008
7.
Latest Chinese Regulations for Imported Drug Registration
8.
Pharmaceutical Distribution in Europe The Emergence of Direct-to-Pharmacy Supply
Stem Cells Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development
With their ability to differentiate and become an ongoing source of cells that make up critical tissues and organs, stem cells have potential for new regenerative therapies and as new research tools for drug developers to test emerging therapies on diseased cells.
For market-watchers in the pharmaceutical industry, the question is what potential they have and where they could take the market. Kalorama Information has tackled that question in Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development. Kalorama analyst Alison Sahoo has built models to determine the best, moderate and worst case scenarios for the three key markets for stem cells:
* Stem Cell Therapeutics (Transplantation)
* Cord Blood Banking and
* Drug development
This report breaks down forecasted revenues and procedure volumes for stem cell technologies for these segments in the following disease areas:
* Cardiovascular disease
* Lung disease
* Arthritis
* Incontinence
* Osteoporosis
* Diabetes
* Cancer
* Orthopedics
* Infertility
* Alzheimers disease
* Burns (severe)
* Lupus
* Parkinsons disease
* Liver failure
* Multiple sclerosis
* Critical limb ischemia
* Crohn's disease
* Sickle cell disease
* Multiple myeloma
* NH lymphoma
* Leukemia
Ths report is the result of exclusive interviews with executives in the stem cell industry, a review of medical and company literature, government databases and publications. As part of this comprehensive analysis of stem cell markets, the following companies were profiled:
* Aastrom Biosciences
* Advanced Cell Technologies
* Brainstorm Cell Therapeutics
* Celegene
* Cord Blood America
* Cord Blood Registry
* Cryo-Cell International
* ES Cell International
* Geron
* Harvest Technologies
* Invitrogen
* Medistem
* Neostem
* Opexa Therapeutics
* Osiris Therapeutics
* Plureon
* Regenetech
* Revivicor
* Stem Cell Sciences
* StemLifeLine
* ThermoGenesis
* VetCell Bioscience
* ViaCell
Mar 1, 2008 250 Pages
Table of Contents
Price: $3,995.00 / GBP2,197.25
Buy Biotechnology Management Reports online with BioPortfolio's secure E-Commerce portal.